Cutaneous Human Polyomavirus Small T Antigens and 4E-BP1 Targeting

Julie H Wu1, Rebecca A Simonette, Thomas Hsiao

  • 1Department of Dermatology, University of Texas Medical School at Houston, Houston, Tex., USA.

Intervirology
|April 8, 2016
PubMed

Insights

Merkel cell polyomavirus (MCPyV) and human polyomavirus 7 (HPyV7) small tumor antigens promote 4E-binding protein 1 (4E-BP1) hyperphosphorylation, potentially driving aggressive cancer phenotypes.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Merkel cell polyomavirus (MCPyV), trichodysplasia spinulosa-associated polyomavirus (TSPyV), human polyomavirus 6 (HPyV6), and human polyomavirus 7 (HPyV7) are linked to skin growths.
  • These polyomaviruses encode small tumor (sT) antigens, which play roles in pathogenesis.

Purpose of the Study:

  • To investigate the differential effects of four human polyomavirus sT antigens on 4E-binding protein 1 (4E-BP1) phosphorylation.
  • To elucidate the potential oncogenic mechanisms mediated by these viral sT antigens.

Main Methods:

  • Analysis of MCPyV, TSPyV, HPyV6, and HPyV7 sT antigens.
  • Assessment of 4E-BP1 serine 65 hyperphosphorylation levels.
  • Identification of 4E-BP1 isoforms, including the δ isoform.

Main Results:

  • MCPyV and HPyV7 sT antigens significantly promoted the hyperphosphorylation of 4E-BP1, favoring the δ isoform.
  • TSPyV and HPyV6 sT antigens showed no significant effect on 4E-BP1 hyperphosphorylation.
  • Differential regulation of 4E-BP1 by distinct polyomavirus sT antigens was observed.

Conclusions:

  • MCPyV sT antigen's role in pathogenicity is confirmed through its effect on 4E-BP1.
  • HPyV7 sT antigen may contribute to oncogenesis via a novel mechanism involving 4E-BP1 hyperphosphorylation.
  • The differential impact of viral sT antigens on 4E-BP1 suggests distinct roles in cutaneous disease development.

Related Concept Videos